Armando Sánchez-Quijano

TL;DR: HIV-related immunodeficiency may be a determinant of higher hepatitis C viremia levels and more severe liver damage and mean interval from estimated time of HCV infection to cirrhosis was significantly longer in HIV-negative than HIV-positive patients.

TL;DR: It is suggested that HIV infection can alter the natural course of chronic parenterally acquired hepatitis C, causing an unusually rapid progression to cirrhosis.

TL;DR: Data from the analysis of naïve T cells, T-cell receptor excision circles (TRECs), and computed tomography scanning of thymic tissue strongly suggest aThymic role in immune reconstitution, at least in patients with depleted baseline TREC levels.

TL;DR: The dosing regimen of MA currently recommended for treating VL is associated with a high rate of serious side effects in HIV-1-infected patients, and treatment with MA was permanently discontinued due to serious adverse effects that included acute pancreatitis, acute renal failure, and leukopenia.

TL;DR: A high rate of HCV genotype 4-harboring cases has been found among HCV-infected individuals in Southern Spain and these individuals could have been wrongly regarded as non-viremic.